Gene symbol | HA | Synonyms | None | Type of gene | protein-coding |
Chromosome | - | Map location | NC_002017.1 (33..1733) | dbXrefs | |
Description | haemagglutinin |
GTO ID | GTC1433 |
Trial ID | NCT01688297 |
Disease | Influenza |
Altered gene | HA |
Therapeutic/Target gene | Therapeutic gene |
Therapy | dsRNA |
Treatment | VXA-A1.1|Ad-HA-dsRNA |
Phase | Phase1 |
Recruitment status | Completed |
Title | Randomized Phase 1 Double-Blinded Placebo Controlled Trial to Determine the Safety and Immunogenicity of an Adenoviral-Vector Based Seasonal Influenza A Vaccine and dsRNA Adjuvant Administered Orally to Healthy Volunteers |
Year | 2012 |
Country | United States |
Company sponsor | Vaxart |
Other ID(s) | VXA02-001 & VXA02-003 |
Vector information | |||||||||||
|
Cohort1: VXA-A1.1_dose level 1 | |||||||
|
|||||||
Cohort2: Placebo | |||||||
|
|||||||
Cohort3: VXA-A1.1_dose level 2 | |||||||
|
|||||||
Cohort4: VXA-A1.1_dose level 3 | |||||||
|